Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.

Molly P HoganJoao Vicente HorvatDara S RossVaradan SevilimeduMaxine S JochelsonLaurie J KirsteinShari B GoldfarbChristopher E ComstockJanice S Sung

Published in: Breast cancer research and treatment (2023)

Contrast-enhanced mammography is an acceptable alternative to breast MRI for the detection of residual disease after neoadjuvant treatment.

Keyphrases